title: NKG2D initiates caspase-mediated CD3zeta degradation and lymphocyte receptor impairments associated with human cancer and autoimmune disease.
authors.affiliation: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
authors.forename: Nobuyoshi
authors.initials: N
authors.lastname: Hanaoka
authors.forename: Bana
authors.initials: B
authors.lastname: Jabri
authors.forename: Zhenpeng
authors.initials: Z
authors.lastname: Dai
authors.forename: Cezary
authors.initials: C
authors.lastname: Ciszewski
authors.forename: Anne M
authors.initials: AM
authors.lastname: Stevens
authors.forename: Cassian
authors.initials: C
authors.lastname: Yee
authors.forename: Hideki
authors.initials: H
authors.lastname: Nakakuma
authors.forename: Thomas
authors.initials: T
authors.lastname: Spies
authors.forename: Veronika
authors.initials: V
authors.lastname: Groh